Agenus (AGEN) Reports Second Quarter 2014 Financial Results
7/24/2014 11:23:32 AM
Agenus Inc. (NASDAQ:AGEN), an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein peptide-based vaccines, and adjuvants, today announced its financial results and business highlights for the second quarter ended June 30, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by